"Plasmapheresis Market to Hit $2.55 Billion by 2030 Amid Rising Autoimmune Disea
The Plasmapheresis Market is anticipated to reach $2.55 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030.n
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
"Plasmapheresis Market to Hit $2.55 Billion by 2030 Amid Rising Autoimmune Diseases"
PlasmapheresisMarket2023-2030 Meticulous Research , a leading global market research company, has released an in- depth report titled, Plasmapheresis Market by Product (Instruments, Disposables), Technology (Membrane Filtration, Centrifugation), Application (Therapeutic [Immunology, Neurology, Hematology], Plasma Collection), End User (Biopharma, Hospitals) - Global Forecast to 2030. Download Free Sample Report: https://www.meticulousresearch.com/download- sample- report/cp_id=3092?utm_source=pdf&utm_medium=social&utm_campaign=produ ct&utm_content=28-06-2024 According to Meticulous Research , the plasmapheresis market is projected to reach $2.55 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. This growth is driven by the rising incidence of autoimmune diseases, increased demand for source plasma by biopharmaceutical companies, and favorable reimbursement policies for plasmapheresis procedures. Additionally, expanding demand for plasmapheresis in emerging markets presents significant growth opportunities. However, market growth is restrained by the high costs associated with plasmapheresis devices and procedures, as well as inherent risks. Limited awareness and access in certain regions also pose significant challenges. Plasmapheresis Market: Future Outlook The plasmapheresis market is segmented by product, technology, application, end user, and geography, with detailed evaluations of industry competitors and country-level market analyses. Product Segment: In 2023, disposables are expected to dominate the market, driven by the consistent use of plasma separation filters and administration sets in plasmapheresis procedures. Technology Segment: Centrifugation is expected to hold the largest market share in 2023, benefiting from the rapid and efficient separation of plasma from blood components. Application Segment: Source Plasma Collection is anticipated to lead the market in 2023 due to rising demand from pharmaceutical and biotechnology companies, increased need for plasma proteins, and growing awareness about plasma donation. Page 1 of 3 Meticulous Research| sales@meticulousresearch.com
PlasmapheresisMarket2023-2030 Browse in Depth: https://www.meticulousresearch.com/product/plasmapheresis- market- 3092?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_conte nt=28-06-2024 End User Segment: Source Plasma Collection Centers are predicted to capture the largest market share in 2023, owing to the growing demand for source plasma for the production of plasma-derived products through fractionation methods. Geographic Insights: The report provides thorough analysis across major regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2023, North America is poised to dominate the plasmapheresis market, followed by Europe and Asia-Pacific. The substantial market share of North America can be attributed to high awareness of plasmapheresis's therapeutic applications, the prevalence of autoimmune diseases, advanced technology adoption, and a robust healthcare infrastructure. Key Players: Leading companies in the plasmapheresis market include Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), SB Kawasumi Laboratories, Inc. (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland). Buy Now: https://www.meticulousresearch.com/Checkout/79432394?utm_source=pdf&utm_ medium=social&utm_campaign=product&utm_content=28-06-2024 About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, Page 2 of 3 Meticulous Research| sales@meticulousresearch.com
PlasmapheresisMarket2023-2030 and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com
